Therapeutic efficacy of Pudilan Xiaoyan Oral Liquid (PDL) for COVID-19 in vitro and in vivo

Registro en:

2059-3635

https://www.nature.com/articles/s41392-020-0176-0

http://hdl.handle.net/20.500.12010/12694

https://doi.org/10.1038/s41392-020-0176-0

http://repositorioslatinoamericanos.uchile.cl/handle/2250/3503430

Autor

Deng, Wei

Xu, Yanfeng

Kong, Qi

Xue, Jing

Yu, Pin

Liu, Jiangning

Lv, Qi

Li, Fengdi

Wei, Qiang

Bao, Linlin

Institución

Universidad Jorge Tadeo Lozano (Colombia)

Materias

Pudilan Xiaoyan Oral Liquid (PDL)

COVID-19 in vitro and in vivo

Mostrar el registro completo del ítem